Cholecystokinin-mediated synaptic function and the treatment of neuropsychiatric disease.
D000818:Animals; D002108:Ceruletide / Q000627:therapeutic use; D002766:Cholecystokinin / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005247:Feeding Behavior / Q000187:drug effects; D006801:Humans; D009043:Motor Activity / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy*; D012844:Sincalide / Q000378:metabolism; D013569:Synapses / Q000187:drug effects*
D011954:Receptors, Dopamine; D002108:Ceruletide; D002766:Cholecystokinin; D012844:Sincalide